BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1741214)

  • 81. Efficacy of short-term growth hormone treatment in prepubertal children with idiopathic short stature.
    Kim HS; Yang SW; Yoo HW; Suh BK; Ko CW; Chung WY; Lee KH; Hwang JS; Ji HJ; Ahn H; Kim DH
    Yonsei Med J; 2014 Jan; 55(1):53-60. PubMed ID: 24339287
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport.
    Guha N; Erotokritou-Mulligan I; Burford C; Strobridge G; Brigg J; Drake T; Bassett EE; Cowan D; Bartlett C; Sönksen PH; Holt RI
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2969-76. PubMed ID: 20410221
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement.
    Kennedy MJ; Davis DA; Smith N; Gaedigk A; Pearce RE; Kearns GL
    Clin Ther; 2008 Sep; 30(9):1687-99. PubMed ID: 18840375
    [TBL] [Abstract][Full Text] [Related]  

  • 84. IGF-I treatment of adult patients with Laron syndrome: preliminary results.
    Laron Z; Klinger B
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):631-8. PubMed ID: 7530175
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effect of long-term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency.
    Seminara S; Merello G; Masi S; Filpo A; La Cauza F; D'Onghia G; Martelli E; Loche S
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):125-30. PubMed ID: 9797856
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
    Holt RI; Böhning W; Guha N; Bartlett C; Cowan DA; Giraud S; Bassett EE; Sönksen PH; Böhning D
    Drug Test Anal; 2015 Sep; 7(9):745-55. PubMed ID: 25645199
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes.
    Nelson AE; Howe CJ; Nguyen TV; Leung KC; Trout GJ; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4424-32. PubMed ID: 16912136
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study.
    Simon D; Prieur AM; Quartier P; Charles Ruiz J; Czernichow P
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2567-73. PubMed ID: 17488793
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Growth hormone secretory patterns in children with short stature.
    Costin G; Kaufman FR
    J Pediatr; 1987 Mar; 110(3):362-8. PubMed ID: 3819936
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Endogenous and stimulated GH secretion, urinary GH excretion, and plasma IGF-I and IGF-II levels in prepubertal children with short stature after intrauterine growth retardation. The Dutch Working Group on Growth Hormone.
    de Waal WJ; Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Drop SL
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):621-30. PubMed ID: 7828352
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Predictors of growth response to growth hormone in otherwise normal short children.
    Zadik Z; Landau H; Limoni Y; Lieberman E
    J Pediatr; 1992 Jul; 121(1):44-8. PubMed ID: 1625091
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The relationship between the response to growth hormone therapy and pre-treatment growth hormone secretory status.
    Hindmarsh PC; Smith PJ; Pringle PJ; Brook CG
    Clin Endocrinol (Oxf); 1988 May; 28(5):559-63. PubMed ID: 3214947
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.
    Iughetti L; Vannelli S; Street ME; Pirazzoli P; Bertelloni S; Radetti G; Capone L; Stasiowska B; Mazzanti L; Gastaldi R; Maggio MC; Predieri B
    Horm Res Paediatr; 2012; 78(5-6):279-87. PubMed ID: 23208451
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Which children should have growth hormone therapy?
    Milner RD
    Lancet; 1986 Mar; 1(8479):483-5. PubMed ID: 2869217
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Serum osteocalcin levels in patients with GH deficiency before and during GH treatment.
    Sartorio A; Conti A; Guzzaloni G; Faglia G
    Acta Paediatr Scand; 1991 Jan; 80(1):100-2. PubMed ID: 2028779
    [No Abstract]   [Full Text] [Related]  

  • 98. Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders.
    Trivedi P; Risteli J; Risteli L; Hindmarsh PC; Brook CG; Mowat AP
    Pediatr Res; 1991 Sep; 30(3):276-80. PubMed ID: 1945568
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Growth hormone is positively associated with surrogate markers of bone turnover during puberty.
    Russell M; Breggia A; Mendes N; Klibanski A; Misra M
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):482-8. PubMed ID: 21535073
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
    Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.